Unichem Laboratories Ltd.

NSE: UNICHEMLAB | BSE: 506690 | ISIN: INE351A01035 | Industry: Pharmaceuticals
| Mid-range Performer

607.65
1.87%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 17.5% YoY to | 360 crore (I-direct estimate: | 361 crore) mainly on account of 31.5% growth in export sales to | 123 crore (I-direct estimate: | 115 crore). Domestic revenues grew 7.8% YoY to | 204 crore (I-direct estimate: | 217 crore) EBITDA margins improved 121 bps YoY to 12.3% (I-direct estimate: 12.5%) mainly due to lower other expenditure. EBITDA increased 30% YoY to | 44 crore in line with I-direct estimate of | 45 crore...
Unichem Laboratories Ltd. is trading above its 30 day SMA of 602.0
More from Unichem Laboratories Ltd.
Recommended